Quick Answer
MIRA PHARMACEUTICALS, INC. reported Stockholders Equity of $10.39 million for fiscal year 2025.
MIRA PHARMACEUTICALS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $10.39M | +372.4% |
| 2024 | $2.20M | -49.7% |
| 2023 | $4.37M | +833.7% |
| 2022 | -$596.2K | -126.4% |
| 2021 | $2.26M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.55M | +111.2% | +1224.8% |
| June 30, 2025 | $569.9K | -74.3% | -56.0% |
| March 31, 2025 | $1.29M | -59.0% | -41.2% |
| December 31, 2024 | $2.20M | -49.7% | -38.4% |
| September 30, 2024 | $3.57M | -56.0% | +61.1% |
| June 30, 2024 | $2.22M | +85.4% | -29.7% |
| March 31, 2024 | $3.16M | +276.4% | -27.8% |
| December 31, 2023 | $4.37M | +833.7% | -46.1% |
- MIRA PHARMACEUTICALS, INC. showed an increase of +372.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, MIRA PHARMACEUTICALS, INC.’s stockholders equity has grown by 359.5% (from $2.26 million to $10.39 million).
- The most recent figure is from MIRA PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: